---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024277"
form_type: "8-K"
ticker: "XAIR"
cik: "0001641631"
company_name: "Beyond Air, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:54:35.529872+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Beyond Air appoints David Webster as Chief Commercial Officer effective July 8, 2024

## Summary
- David Webster appointed CCO, effective July 8, 2024, with over 20 years life sciences experience.
- Previously CEO of Body Vision Medical; led commercialization of Lung Vision system.
- Received inducement stock option for 125,000 shares, vesting over four years starting July 8, 2024.
- Company expects Webster to drive LungFit PH market share gains and strengthen commercial team.

## SEC filing metadata
- accession: 0001493152-24-024277
- form_type: 8-K
- ticker: XAIR
- cik: 0001641631
- company_name: Beyond Air, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/0001493152-24-024277-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024277
- JSON: https://secwatch.observer/filing/0001493152-24-024277.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024277.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.